Veru Incis A Biopharmaceutical Company Based In Miamifloridafocused On Developing Innovative Medicines For Cardiometabolic Diseasesoncologyand Viral Induced Acute Respiratory Distress Syndromeards Established In 1971 And Rebranded In 2017Veru Is Dedicated To Advancing Treatments That Address Significant Health Challenges The Company Operates In Several Key Areasincluding Oncologywhere It Is Developing Therapies For Various Cancerssuch As Breast Cancernotable Products Include Sabizabulinaimed At Treating Viral Induced Ardsand Enobosarmwhich Targets Metabolic Conditions And Breast Cancerveru Also Markets The Fc2 Female Condomproviding Protection Against Unplanned Pregnancy And Sexually Transmitted Infectionswith A Commitment To Research And Developmentveru Invests Heavily In Bringing New Treatments To Marketthe Company Is Publicly Traded On Nasdaq Under The Ticker Symbol Veru And Employs Around 210 People
No conferences found for this company.
| Company Name | Veru Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
